Get App Open
In App
Credit Cards
Open App
you are here:

Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE044A01036 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 01, 16:01
1636.15 41.20 (2.58%)
Volume
AVERAGE VOLUME
5-Day
153,116
10-Day
150,955
30-Day
123,210
182,439
  • Prev. Close

    1594.95

  • Open Price

    1606.35

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 01, 15:59
1636.20 41.90 (2.63%)
Volume
AVERAGE VOLUME
5-Day
3,459,844
10-Day
2,771,731
30-Day
2,775,000
3,109,095
  • Prev. Close

    1594.30

  • Open Price

    1611.90

  • Bid Price (Qty.)

    1636.20 (60)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Profit & Loss account of Sun Pharmaceutical Industries (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 22,625.88 19,843.53 20,394.63 15,518.50 12,570.93  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 22,625.88 19,843.53 20,394.63 15,518.50 12,570.93  
Total Operating Revenues 23,003.33 20,275.17 20,812.14 15,585.98 12,803.21  
Other Income 369.43 465.76 279.03 957.92 150.22  
Total Revenue 23,372.76 20,740.93 21,091.17 16,543.90 12,953.43  
EXPENSES  
Cost Of Materials Consumed 4,690.67 4,429.38 5,165.63 4,584.97 3,809.11  
Purchase Of Stock-In Trade 1,359.53 994.41 1,126.46 1,248.60 1,199.63  
Operating And Direct Expenses 0.00 344.45 313.75 275.23 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -69.17 180.32 -237.93 -183.18 -214.84  
Employee Benefit Expenses 2,608.26 2,373.95 2,156.95 2,000.78 1,798.45  
Finance Costs 893.21 784.08 472.18 388.10 256.98  
Depreciation And Amortisation Expenses 1,238.27 1,600.62 1,600.87 1,349.95 586.81  
Other Expenses 7,621.42 6,365.05 5,814.42 4,752.06 3,274.86  
Total Expenses 18,342.19 17,072.26 16,412.33 14,416.51 10,711.00  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 5,030.57 3,668.67 4,678.84 2,127.39 2,242.43  
Exceptional Items 0.00 -219.02 -2,937.79 -1,820.53 -89.56  
Profit/Loss Before Tax 5,030.57 3,449.65 1,741.05 306.86 2,152.87  
Tax Expenses-Continued Operations  
Current Tax 908.62 546.10 752.77 -553.58 244.91  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax -160.67 45.37 -702.44 960.43 -231.74  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 747.95 591.47 50.33 406.85 13.17  
Profit/Loss After Tax And Before ExtraOrdinary Items 4,282.62 2,858.18 1,690.72 -99.99 2,139.70  
Profit/Loss From Continuing Operations 4,282.62 2,858.18 1,690.72 -99.99 2,139.70  
Profit/Loss For The Period 4,282.62 2,858.18 1,690.72 -99.99 2,139.70  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 17.80 11.90 7.00 -0.40 8.92  
Diluted EPS (Rs.) 17.80 11.90 7.00 -0.40 8.92  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 3,613.97 2,898.16 2,519.30 2,158.91 1,559.06  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Equity Dividend Rate (%) 1,600.00 1,350.00 1,150.00 1,000.00 750.00  
Source : Dion Global Solutions Limited

Results of Sun Pharma